Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Northshore Oncology Associates-Covington
mi
from
Covington, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Southern Cancer Center PC-Daphne
mi
from
Daphne, AL
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
UM Sylvester Comprehensive Cancer Center at Deerfield Beach
mi
from
Deerfield Beach, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Ascension Saint John Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Union Hospital of Cecil County
mi
from
Elkton, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
INOVA Fair Oaks Hospital
mi
from
Fairfax, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
IMG Hematology Oncology 8501
mi
from
Fairfax, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Saint Mary's
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Hattiesburg Clinic - Hematology/Oncology Clinic
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
UM Sylvester Comprehensive Cancer Center at Hollywood
mi
from
Hollywood, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Cancer Care Inc-Liliha
mi
from
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Community Cancer Center East
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Baptist MD Anderson Cancer Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
CHRISTUS Saint Patrick Hospital
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
OptumCare Cancer Care at Fort Apache
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Marshfield Medical Center-Marshfield
mi
from
Marshfield, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Southern Cancer Center PC-Springhill
mi
from
Mobile, AL
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
ProHealth D N Greenwald Center
mi
from
Mukwonago, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Baptist Memorial Hospital and Cancer Center-Union County
mi
from
New Albany, MS
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
ProHealth Oconomowoc Memorial Hospital
mi
from
Oconomowoc, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Chicago Medicine-Orland Park
mi
from
Orland Park, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Geisinger Cancer Services-Pottsville
mi
from
Pottsville, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Reid Health
mi
from
Richmond, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Cancer Center - Rocklin
mi
from
Rocklin, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Sloan Kettering Rockville Centre
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
CHRISTUS Highland Medical Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Sturgeon Bay
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Clarksburg, WV
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Dunwoody, GA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Franklin, OH
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Greer, SC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Huntington Park, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Lomita, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Manhattan, KS
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Media, PA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Saint Cloud, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
San Jose, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Wichita, KS
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling, Phase III
Updated: 6/13/2016
Clinical Research Facility
mi
from
Baker, LA
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling, Phase III
Updated: 6/13/2016
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling, Phase III
Updated: 6/13/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling, Phase III
Updated: 6/13/2016
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling, Phase III
Updated: 6/13/2016
Clinical Research Facility
mi
from
Stockton, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Bountiful, UT
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Clarksville, TN
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Edgewater, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Elizabethtown, KY
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Fall River, MA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
McMurray, PA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Murrieta, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Paducah, KY
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
mi
from
Washington, MO
Click here to add this to my saved trials
Endocrinology Clinical Trial
Peer Education About Weight Steadiness
Status: Enrolling, Phase I, II
Updated: 10/26/2017
Mahomet Seymour-Junior High School
mi
from
Mahomet, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Putting CDSMP to Work
Status: Enrolling
Updated: 12/31/1969
National Beef
mi
from
Moultrie, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Putting CDSMP to Work
Status: Enrolling
Updated: 12/31/1969
Valdosta City Schools
mi
from
Valdosta, GA
Click here to add this to my saved trials
Epilepsy Clinical Trial
TAK-935 Multiple Rising Dose Study in Healthy Participants
Status: Enrolling, Phase I
Updated: 12/1/2015
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)
Status: Enrolling, Phase III
Updated: 12/31/1969
Envision Cancer Care, LLC
mi
from
Laredo, TX
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)
Status: Enrolling, Phase III
Updated: 12/31/1969
Prairie Lakes Cancer Center
mi
from
Watertown, SD
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
St. Vincent's HealthCare
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Christus Trinity Mother Frances Health System
mi
from
Tyler, TX
Click here to add this to my saved trials
Barrett Esophagus Clinical Trial
Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System
Status: Enrolling
Updated: 12/31/1969
Northwell Health
mi
from
Manhasset, NY
Click here to add this to my saved trials
Neoplasms, Advanced or Metastatic Clinical Trial
MLN1117 in Combination With Docetaxel, Paclitaxel, and Other Investigational Anticancer Agents to Treat Participants With Gastric and Gastroesophageal Adenocarcinoma
Status: Enrolling, Phase I
Updated: 3/22/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
Hershey, PA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Lankenau Medical Center
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Delayed Onset Muscle Soreness, DOMS Clinical Trial
Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness (DOMS)
Status: Enrolling, Phase III
Updated: 11/4/2015
Clinical Research Facility
mi
from
South Miami, FL
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Galliera Hospital
mi
from
Genoa,
Click here to add this to my saved trials
Neurotrophic Keratopathy Clinical Trial
Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Midwest Cornea Associates, LLC
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Neurotrophic Keratopathy Clinical Trial
Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Insight Vision Group
mi
from
Parker, CO
Click here to add this to my saved trials
Fetal Alcohol Syndrome Clinical Trial
Prenatal Alcohol Biomarker Study in Uruguay
Status: Enrolling, Phase
Updated: 12/31/1969
Clínica Ginecología/Obstétrica del Hospital General de las Fuerzas Armadas de Uruguay
mi
from
Montevideo,
Click here to add this to my saved trials
Relapsed/Refractory Mantle Cell Lymphoma Clinical Trial
A Phase 2 Multicenter Study Evaluating Subjects With Relapsed/Refractory Mantle Cell Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Robert W. Franz Cancer Research Center
mi
from
Portland, OR
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
Status: Enrolling, Phase III
Updated: 7/6/2016
Glenmark Investigational Site 49
mi
from
Tempe, AZ
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
Status: Enrolling, Phase III
Updated: 7/6/2016
Glenmark Investigational Site 57
mi
from
West Columbia, SC
Click here to add this to my saved trials
Clinical Trial
Web-based Implementation for the Science of Enhancing Resilience Study
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deconness Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Metastatic Lesions in Vertebral Bodies Clinical Trial
The STAR™ Tumor Ablation Registry
Status: Enrolling
Updated: 3/31/2016
Southern California Institute of Neurological Surgery
mi
from
Escondido, CA
Click here to add this to my saved trials
Advanced Cancers Clinical Trial
A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Pinnacle Research
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Nephrology / Urology, Rheumatology Clinical Trial
Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Alabama-Birmingham-Parent Account
mi
from
Birmingham, AL
Click here to add this to my saved trials
Nephrology / Urology, Rheumatology Clinical Trial
Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Renal Disease Research Institute
mi
from
Dallas, TX
Click here to add this to my saved trials
Metastatic Breast Cancer (MBC) Clinical Trial
Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memorial Sloan Kettering Monmouth
mi
from
Middletown, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation Study in Solid Tumors and a Dose Expansion Study of PRN1371 in Adult Patients With Metastatic Urothelial Carcinoma
Status: Enrolling, Phase I
Updated: 12/31/1969
Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital
mi
from
Barcelona,
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation Study in Solid Tumors and a Dose Expansion Study of PRN1371 in Adult Patients With Metastatic Urothelial Carcinoma
Status: Enrolling, Phase I
Updated: 12/31/1969
UCSF Helen Diller Family Comprehensive Cancer Cener
mi
from
San Francisco, CA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Decipher Genomics Resource Information Database
Status: Enrolling, Phase
Updated: 12/31/1969
Northwestern University Feinberg School of Medicine
mi
from
Evanston, IL
Click here to add this to my saved trials